butabarbital brand name butisol prescription barbiturate sleep aid anxiety medication butabarbital particularly fast onset effects short duration action compared barbiturates makes useful certain applications treating severe insomnia relieving general anxiety relieving anxiety surgical procedures however also relatively dangerous particularly combined alcohol rarely used although still prescribed eastern european south american countries intermediate duration action gives butabarbital abuse potential slightly lower secobarbital butabarbital hydrolyzed rstereoisomer sstereoisomer butabarbital also sold combination belladonna alkaloids brand name butibel belladonna added antispasmodic effect product contains low dose butabarbital combined standardised mix belladonna alkaloids used antispasmodic taken relieve cramping spasms stomach intestines used also decrease amount acid formed stomach another similar product donnatal contains belladonna alkaloids combined phenobarbital barbiturates first discovered medical use research bayer showed barbital effective sedative mid century habit forming nature barbiturates behavioral side effects first benzodiazepines commonly administered today similar sedative hypnotic properties reduced risk physical dependence barbiturate drugs butabarbital sodium used shortterm acute treatment strict doctor supervision barbiturates nonselective depressants central nervous system inducing drowsiness mild sedative effects barbiturate hypnotics used treatment sleep anxiety disorders calming sedative properties however usually restricted short term use due risk butabarbital commonly known butisol commercially approved schedule iii drug us canada used shortterm treatment anxiety disorders presurgical sedative aid approved commercial forms available tablet elixir recently butabarbital approved medical use brand name butisol butisol sodium manufactured meda pharmaceuticals schedule iii controlled substance due high risk abuse often administered orally either sodium solution tablet however also given intravenous injection tablets contain either mg mg butabarbital sodium alcoholvol solution preoperative sedation adults administered mg prior surgery varying doses pediatric geriatric effects oral doses often felt within hour administration lasting somewhere six eight hours nonselective depressant cns butabarbital sodium used sedative hypnotic depending dose induce drowsiness sleep reduce anxiety butabarbital sodium used presurgical anesthetic aid shortterm treatment sleep anxiety disorders short term sleep maintenance induction butabarbital sodium treatment recommended limited two weeks begins lose half life approximately eliminated primarily hepatic microsomal enzymes excreted urine butabarbital sodium schedule iii controlled substance us canada due risk abuse dependence psychoactive substance butabarbital drugs often abused risk acute intoxication addiction barbiturates butabarbital thought habitforming addictive severe risks withdrawal including due high risk dependence overdose use butabarbital highly regulated become less common clinical application taking butabarbital asked watch signs severe allergic reaction swelling difficulty breathing less serious side effects include dizziness drowsiness excitation headache nausea vomiting constipation psychiatric disturbances hallucinations agitation confusion depression memory problems ataxia difficulty breathing slow heartbeat could signs serious adverse effects brought attention doctor immediately hypersensitivity barbiturates history porphyria discuss doctor using butisol sodium treatment butabarbital also shown interact medicines talk doctor taking monoamine oxidase inhibitors maois betablockers oralcontraceptives medications efficacy may low doses butabarbital shown clinically induce drowsiness depressing sensory cortex motor activity rare cases butabarbital shown produce small bursts excitement euphoria prior sedative effects butabarbital highly potent drug however addictive properties small variations dose result significant escalation butabarbital sedative hypnotic member barbiturate family relatively fast acting short duration producing range effects mild sedation hypnosis function overdose butabarbital result deep coma even death butabarbituates rapidly distributed absorbed brain liver kidneys one lipophilic barbiturates butabarbital crosses blood brain barrier relative ease slightly potent less lipophilic barbiturates butabarbital weak acid commonly administered orally sodium salt hours oral administration butabarbital sodium reaches peak plama concentrations ugml sedation ugml induce sleep absorbed via gi absorbed butabarbitals effects duration hours orally administered hours following intravaneous administration general consensus halflife approximately however also reported one study half life primary way body terminates activity oxidation radicals biotransformations contributing lesser butabarbital metabolized almost entirely liver products including polar alcohols ketones phenols carboxylic acids renally excreted halflife hr duration hr onset min enzymes induced excretion urine mechanism action barbiturates exert effect yetwhen completely understood however believed involved enhancement gaba inhibitory neurotransmitter activity cns via gabaa butabarbital member drug class acutely potentiates inhibitory gabaergic tone binding specific site associated ionophore gabaa butabarbitals binding causes channel remain open longer thus prolongs postsynaptic inhibition less well characterized effects barbiturates include direct inhibition ampatype glutamate receptors suppressing excitatory glutamatergic httpsenwikipediaorgwikibutabarbital